drugset / Trial / NCT06543303
Evaluation of BTV100 in Subjects With Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).
Timeline
- Start
- 2024-12-31
- Primary completion
- 2026-01-14
- Completion
- 2026-01-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cevimeline | Small molecule | 1 % | Other |
| Subject | Cevimeline | Small molecule | 2 % | Other |
| Subject | Cevimeline | Small molecule | 4 % | Other |